1. Home
  2. LPRO vs KRRO Comparison

LPRO vs KRRO Comparison

Compare LPRO & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Open Lending Corporation

LPRO

Open Lending Corporation

HOLD

Current Price

$1.21

Market Cap

142.4M

Sector

Finance

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$14.01

Market Cap

150.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPRO
KRRO
Founded
2000
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
142.4M
150.0M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
LPRO
KRRO
Price
$1.21
$14.01
Analyst Decision
Buy
Buy
Analyst Count
6
12
Target Price
$2.46
$34.80
AVG Volume (30 Days)
560.5K
227.5K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
96.46
N/A
EPS
N/A
N/A
Revenue
N/A
$6,392,000.00
Revenue This Year
$10.12
N/A
Revenue Next Year
$17.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
181.46
52 Week Low
$0.70
$5.20
52 Week High
$2.70
$55.89

Technical Indicators

Market Signals
Indicator
LPRO
KRRO
Relative Strength Index (RSI) 38.62 65.53
Support Level N/A $13.80
Resistance Level $1.96 $14.96
Average True Range (ATR) 0.10 0.88
MACD -0.00 0.20
Stochastic Oscillator 6.74 90.36

Price Performance

Historical Comparison
LPRO
KRRO

About LPRO Open Lending Corporation

Open Lending Corp is a provider of lending enablement and risk analytics to credit unions, regional banks, finance companies and the captive finance companies of automakers (OEM captive finance companies). Through its flagship product, LPP, its customers, collectively referred to herein as automotive lenders or lenders, make automotive consumer loans to underserved near-prime and non-prime borrowers by harnessing its risk-based interest rate pricing models, powered by its proprietary data and real-time underwriting of automotive loan default insurance coverage from insurers.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: